Medicure Company Profile (CVE:MPH)

About Medicure (CVE:MPH)

Medicure logoMedicure Inc. (Medicure) is a pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. The Company operates in the biopharmaceutical industry segment. The Company's primary operating focus is on the sale and marketing of its acute care cardiovascular drug, AGGRASTAT (tirofiban hydrochloride) owned by its subsidiary, Medicure International, Inc. and distributed in the United States and its territories through the Company's United States subsidiary, Medicure Pharma, Inc. AGGRASTAT, a glycoprotein IIb/IIIa inhibitor (GPI), is used for the treatment of acute coronary syndrome (ACS). The Company is also engaged in the development of TARDOXAL for neurological disorders, such as Tardive Dyskinesia (TD). The Company has completed Phase IIa stage of development for TARDOXAL. The Company is also developing Transdermal AGGRASTAT, a cure for acute cardiology. Transdermal AGGRASTAT is in preclinical-stage of development.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: CVE:MPH
  • CUSIP: N/A
  • Web: www.medicure.com/
Capitalization:
  • Market Cap: C$125.38 million
  • Outstanding Shares: 15,633,000
Average Prices:
  • 52 Week Range: C$5.48 - C$10.67
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: N/A
Sales & Book Value:
  • Annual Revenue: C$53.05 million
  • Price / Sales: 2.36
  • Book Value: C$2.12 per share
  • Price / Book: 3.78
Profitability:
  • EBIDTA: C$13.98 million
  • Net Margins: 6.66%
  • Return on Equity: 16.97%
  • Return on Assets: 2.87%
Misc:
  • Average Volume: 5,792 shs.
  • Short Ratio: 1.69
 

Frequently Asked Questions for Medicure (CVE:MPH)

What is Medicure's stock symbol?

Medicure trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MPH."

How were Medicure's earnings last quarter?

Medicure Inc (CVE:MPH) announced its quarterly earnings results on Wednesday, May, 24th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by $0.37. The firm earned $8.71 million during the quarter, compared to analyst estimates of $14.50 million. Medicure had a net margin of 6.66% and a return on equity of 16.97%. View Medicure's Earnings History.

When will Medicure make its next earnings announcement?

Medicure is scheduled to release their next quarterly earnings announcement on Wednesday, November, 8th 2017. View Earnings Estimates for Medicure.

Who are some of Medicure's key competitors?

Who are Medicure's key executives?

Medicure's management team includes the folowing people:

  • Albert D. Friesen Ph.D., Chairman of the Board, President, Chief Executive Officer
  • James F Kinley CA, Chief Financial Officer, Secretary
  • Brent Fawkes, Director
  • Gerald P. McDole, Independent Director
  • Arnold Naimark, Independent Director
  • Peter Quick, Independent Director

How do I buy Medicure stock?

Shares of Medicure and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Medicure's stock price today?

One share of Medicure stock can currently be purchased for approximately C$8.02.


MarketBeat Community Rating for Medicure (CVE MPH)
Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  36 (Vote Outperform)
Underperform Votes:  21 (Vote Underperform)
Total Votes:  57
MarketBeat's community ratings are surveys of what our community members think about Medicure and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Medicure (CVE:MPH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Medicure (CVE:MPH)
Show:
DateFirmActionRatingPrice TargetDetails
5/4/2016M PartnersReiterated RatingBuyView Rating Details
1/12/2016MackieBoost Price TargetBuyC$8.00View Rating Details
(Data available from 9/23/2015 forward)

Earnings

Earnings History for Medicure (CVE:MPH)
Earnings by Quarter for Medicure (CVE:MPH)
Earnings History by Quarter for Medicure (CVE MPH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2017        
5/24/2017C$0.04C($0.33)C$14.50 millionC$8.71 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Medicure (CVE:MPH)
2017 EPS Consensus Estimate: $0.96
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.09$0.09$0.09
Q2 20171$0.27$0.27$0.27
Q3 20171$0.29$0.29$0.29
Q4 20171$0.31$0.31$0.31
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Medicure (CVE:MPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Medicure (CVE:MPH)
Insider Trades by Quarter for Medicure (CVE:MPH)
Insider Trades by Quarter for Medicure (CVE:MPH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/3/2017Graeme William MerchantInsiderBuy1,000C$7.07C$7,070.00
5/2/2017Albert David FriesenDirectorBuy1,100C$7.59C$8,349.00
3/17/2016Albert David FriesenDirectorBuy1,100C$5.55C$6,105.00
3/16/2016Graeme William MerchantInsiderBuy1,650C$6.40C$10,560.00
3/11/2016Graeme William MerchantInsiderBuy1,500C$6.30C$9,450.00
3/8/2016Graeme William MerchantInsiderSell6,300C$7.01C$44,163.00
9/9/2015Elliott International CapitalInsiderSell1,426,002C$2.98C$4,249,485.96
1/7/2015Albert David FriesenDirectorBuy2,900C$2.01C$5,829.00
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Medicure (CVE:MPH)
Latest Headlines for Medicure (CVE:MPH)
Source:
DateHeadline
thestreet.com logoSierra Wireless Breaks Below 200-Day Moving Average - Notable For SW
www.thestreet.com - August 5 at 4:08 AM
americanbankingnews.com logoMedicure Inc (MPH) Set to Announce Earnings on Monday
www.americanbankingnews.com - August 3 at 12:06 PM
thestreet.com logoTSL Crosses Above 2% Yield Territory
www.thestreet.com - July 21 at 2:39 AM
thestreet.com logoCMG Crosses Below Key Moving Average Level
www.thestreet.com - July 18 at 11:47 PM
thestreet.com logoNotable Two Hundred Day Moving Average Cross - CUP-U
www.thestreet.com - July 18 at 6:23 AM
thestreet.com logoNotable Two Hundred Day Moving Average Cross - SJR-A
www.thestreet.com - July 14 at 6:36 AM
thestreet.com logoMJN Crosses Above Key Moving Average Level
www.thestreet.com - July 13 at 6:54 AM
nasdaq.com logoMedicure Closes Acquisition of Additional Interests in Apicore
www.nasdaq.com - July 13 at 6:54 AM
prnewswire.com logoMedicure Exercises Option to Acquire Additional Interests in Apicore - PR Newswire (press release)
www.prnewswire.com - July 12 at 4:22 AM
thestreet.com logoEx-Div Reminder For Asian Television Network International (SAT)
www.thestreet.com - July 11 at 2:23 AM
benzinga.com logoMedicure Exercises Option to Acquire Additional Interests in Apicore
www.benzinga.com - July 11 at 2:23 AM
thestreet.com logoMedical Facilities Corp Enters Oversold Territory
www.thestreet.com - July 8 at 12:43 PM
prnewswire.com logoMedicure Provides Update on Apicore Purchase Option - PR Newswire (press release)
www.prnewswire.com - July 4 at 2:27 AM
thestreet.com logoAltius Minerals About To Put More Money In Your Pocket (ALS)
www.thestreet.com - July 1 at 2:29 AM
thestreet.com logoGSY Crosses Below Key Moving Average Level
www.thestreet.com - June 30 at 1:46 AM
thestreet.com logoTOS Makes Bullish Cross Above Critical Moving Average
www.thestreet.com - June 27 at 11:46 PM
thestreet.com logoMRG-UN Dividend Yield Pushes Past 4%
www.thestreet.com - June 27 at 5:50 AM
thestreet.com logoNorth American Palladium Breaks Below 200-Day Moving Average - Notable For PDL
www.thestreet.com - June 21 at 7:46 PM
thestreet.com logoKeg Royalties Income Fund (KEG-UN) Shares Cross 5% Yield Mark
www.thestreet.com - June 20 at 7:38 PM
thestreet.com logoRelative Strength Alert For Goeasy (GSY)
www.thestreet.com - June 16 at 7:51 AM
thestreet.com logoRelative Strength Alert For Goeasy (GSY)
www.thestreet.com - June 16 at 7:51 AM
thestreet.com logoCash Dividend On The Way From Economic Investment Trust Limited (EVT)
www.thestreet.com - June 9 at 6:49 PM
thestreet.com logoIBI Group Enters Oversold Territory (IBG)
www.thestreet.com - June 8 at 7:32 PM
thestreet.com logoRelative Strength Alert For Acasta Enterprises (AEF)
www.thestreet.com - June 7 at 11:20 PM
thestreet.com logoOneREIT (ONR-UN) Shares Cross 8% Yield Mark
www.thestreet.com - June 6 at 7:17 PM
thestreet.com logoATP Makes Bullish Cross Above Critical Moving Average
www.thestreet.com - June 2 at 8:00 PM
thestreet.com logoAltius Minerals Becomes Oversold (ALS)
www.thestreet.com - May 31 at 6:57 PM
thestreet.com logoCHW Dividend Yield Pushes Past 7%
www.thestreet.com - May 30 at 6:19 PM
americanbankingnews.com logoFY2017 EPS Estimates for Medicure Inc (MPH) Lowered by M Partners
www.americanbankingnews.com - May 29 at 7:24 AM
americanbankingnews.com logoMedicure Inc (MPH) Posts Quarterly Earnings Results
www.americanbankingnews.com - May 26 at 12:38 AM
americanbankingnews.com logoAnalysts Set Expectations for Medicure Inc's Q1 2017 Earnings (MPH)
www.americanbankingnews.com - May 25 at 7:18 AM
americanbankingnews.com logoM Partners Comments on Medicure Inc's FY2017 Earnings (MPH)
www.americanbankingnews.com - May 24 at 8:32 AM
thestreet.com logoMedicure Becomes Oversold (MPH)
www.thestreet.com - May 23 at 6:10 PM
thestreet.com logoInput Capital (INP) Shares Cross 2% Yield Mark
www.thestreet.com - May 19 at 11:16 AM
bizjournals.com logoMedicure Q1 Results and Conference Call Dates
www.bizjournals.com - May 19 at 11:16 AM
thestreet.com logoAutoCanada (ACQ) Shares Cross 2% Yield Mark
www.thestreet.com - May 16 at 6:24 PM
thestreet.com logoNotable Two Hundred Day Moving Average Cross - SII
www.thestreet.com - May 15 at 6:00 PM
thestreet.com logoOversold Conditions For Badger Daylighting (BAD)
www.thestreet.com - May 13 at 8:48 AM
thestreet.com logoCWX Crosses Above Key Moving Average Level
www.thestreet.com - May 12 at 1:51 AM
thestreet.com logoAltius Minerals Is Now Oversold (ALS)
www.thestreet.com - May 10 at 6:42 PM
thestreet.com logoOversold Conditions For Stingray Digital Group (RAY-A)
www.thestreet.com - May 9 at 6:17 PM
thestreet.com logoRSI Makes Bullish Cross Above Critical Moving Average
www.thestreet.com - May 5 at 11:58 PM
thestreet.com logoRSI Alert: Alaris Royalty (AD) Now Oversold
www.thestreet.com - May 4 at 6:41 PM
thestreet.com logoACQ.CA Makes Notable Cross Below Critical Moving Average
www.thestreet.com - May 3 at 5:40 PM
thestreet.com logoSilvercorp Metals (SVM) Shares Cross Below 200 DMA
www.thestreet.com - May 1 at 5:36 PM
americanbankingnews.com logoM Partners Weighs in on Medicure Inc's FY2017 Earnings (MPH)
www.americanbankingnews.com - May 1 at 9:20 AM
thestreet.com logoCBL.CA Dividend Yield Pushes Past 7%
www.thestreet.com - April 29 at 8:24 AM
prnewswire.com logoMedicure Reports Financial Results for Quarter and Year Ended December 31, 2016 - PR Newswire (press release)
www.prnewswire.com - April 28 at 7:39 PM
thestreet.com logoFC Crosses Above 7% Yield Territory
www.thestreet.com - April 28 at 9:11 AM
thestreet.com logoLBS Crosses Above 12% Yield Territory
www.thestreet.com - April 26 at 11:44 PM

Social

Chart

Medicure (MPH) Chart for Saturday, September, 23, 2017

This page was last updated on 9/23/2017 by MarketBeat.com Staff